Apr 8 2020 |
OIG Releases Policy Statement on AKS Enforcement Discretion During COVID-19 Pandemic |
von Briesen & Roper, s.c. |
Apr 8 2020 |
COVID-19 Update: When Computers Invent: How the Use of Artificial Intelligence to Treat COVID-19 Highlights Novel Inventorship Issues |
Cadwalader, Wickersham & Taft LLP |
Apr 8 2020 |
CMS Guidelines for SNFs During COVID-19 Pandemic |
Much Shelist, P.C. |
Apr 8 2020 |
Making Sense of FDA’s Recent Guidances on Personal Protective Equipment (PPE) |
Womble Bond Dickinson (US) LLP |
Apr 8 2020 |
New DOJ Guidance Addresses Drug prescriptions, Price-Gouging, and Antitrust Concerns in the Wake of COVID-19 |
Dinsmore & Shohl LLP |
Apr 8 2020 |
CMS Issues Nationwide Blanket Waivers of Stark Law and OIG Issues an AKS Policy Statement |
McDermott Will & Schulte LLP |
Apr 7 2020 |
Personalized Medicine Coalition Releases Spring 2020 Newsletter Amid COVID-19 |
Foley & Lardner LLP |
Apr 7 2020 |
Coronavirus HIPAA Enforcement Discretion FAQ |
Dinsmore & Shohl LLP |
Apr 7 2020 |
FFCRA - U.S. DOL Issues Regulations For Implementing Emergency Paid Sick Leave Act and Emergency Family and Medical Leave Expansion Act |
von Briesen & Roper, s.c. |
Apr 7 2020 |
Nota Bene Episode 73: “Quarantine and Chill”: Will COVID-19 Impact the Cannabis Industry? with Whitney Hodges |
Sheppard, Mullin, Richter & Hampton LLP |
Apr 7 2020 |
DOJ Files False Claims Act Lawsuit Against Anthem for “One-Sided” Chart Review Practices |
Mintz |
Apr 7 2020 |
CARES Act Brings Changes to Federal Substance Use Disorder Privacy Law |
Greenberg Traurig, LLP |
Apr 7 2020 |
A Review of the Affordable Care Act at 10 Years |
Mintz |
Apr 7 2020 |
FDA Expands Face Mask Enforcement Policy to Allow Imports of KN95 Respirators |
Mintz |
Apr 7 2020 |
Crossing State Lines During the COVID-19 Pandemic: Self-Quarantine Requirements |
Pierce Atwood LLP |
Apr 7 2020 |
Michigan Governor’s Executive Order Sets Further Restrictions, Prohibits Discrimination |
Barnes & Thornburg LLP |
Apr 7 2020 |
“Twisted” Path to New Trial for Dr. Paulus |
Squire Patton Boggs (US) LLP |
Apr 7 2020 |
Medicaid Program Response to COVID-19 |
Polsinelli PC |
Apr 6 2020 |
Dallas County Judge Jenkins Issues Stay-at-Home Order Through April 30, 2020 |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Apr 6 2020 |
HHS OIG says “Ditto” to HHS Blanket Stark Waivers for Purposes of the Anti-Kickback Statute |
Squire Patton Boggs (US) LLP |
Apr 6 2020 |
CARES Act Prompts Changes to Employer-Sponsored Health Plans |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Apr 6 2020 |
OSHA Relaxes Enforcement to Permit Use of N95s Certified in Certain Countries |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Apr 6 2020 |
Leasing Residence Halls to Municipalities and Hospitals for COVID-19 Relief |
Steptoe & Johnson PLLC |
Apr 6 2020 |
PPMs and the Affiliate Conundrum under the CARES Act—Including April 3, 2020 SBA Affiliate Guidance |
Polsinelli PC |
Apr 6 2020 |
COVID-19 and Nursing Homes FAQ |
Dinsmore & Shohl LLP |
Apr 6 2020 |
Highlights of DOL Temporary Rule on Expanded FMLA and Paid Sick Leave |
Dinsmore & Shohl LLP |
Apr 6 2020 |
U.S. Department of Justice Issues First COVID-19-Related Business Review Letter to Medical Supplies Distributors |
Mintz |
Apr 6 2020 |
What West Virginia Employers Need to Know About the State Response to COVID-19 |
Jackson Lewis P.C. |
Apr 6 2020 |
CMS “Hospitals Without Walls” Waiver: Looking To ASCs to Provide Relief |
Sheppard, Mullin, Richter & Hampton LLP |
Apr 6 2020 |
Local Impact of the CARES Act and Potential New Infrastructure Bill |
Bilzin Sumberg |
Apr 6 2020 |
COVID-19: New Jersey Takes Action to Raise Health Care Personnel Levels |
Epstein Becker & Green, P.C. |
Apr 6 2020 |
CMS Expands Ambulatory Surgery Centers’ Role in Response to COVID-19 Pandemic |
Jones Walker LLP |
Apr 6 2020 |
COVID-19: New Florida Executive Order on Telehealth and Immunization Coverage for State Employees During Public Health Emergency |
Foley & Lardner LLP |
Apr 6 2020 |
Mexico’s Ministry of Health Cites Force Majeure in Declaring National Sanitary Emergency Due to COVID-19 |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Apr 5 2020 |
Exemptions and Considerations for the Treatment of Opioid Use Disorder During the COVID-19 Emergency |
McDermott Will & Schulte LLP |